Deurali-Janta Pharmaceuticals
Antihypertensive/ACE inhibitor
210 / Per 10 Tablet
Competitively inhibits angiotensin I-converting enzyme, preventing conversion of angiotensin I to angiotensin II, a potent vasoconstrictor. Clinical consequences include decreased sodium and fluid retention, decreased BP, and increased diuresis.
Sk+f
Rs. 51
Intas Pharmaceuticals Ltd
Rs. 70
Nepal Pharmaceuticals Lab...
Rs. 98
Cadila Pharmaceuticals Lt...
Rs. 131.76
Sun Pharmaceutical Indust...
Rs. 76.1
We are currently closed. Our services will resume very soon. We apologize for the inconvenience caused.
Login To Review